Storys zum Thema Medizin, Gesundheit
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- Ein Dokumentmehr
Versameb raises CHF 6.4 million in Seed C round and strengthens the team
Basel (ots) - Versameb AG, a Swiss biopharmaceutical company, announced today the successful closing of a CHF 6.4 million Seed C financing round, bringing the total capital raised to date to CHF 11.8 million. Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs. The proceeds of this financing round will be used to expand ...
mehrDiscovery of potential novel therapeutic target for non-alcoholic fatty liver disease
mehrSix Components of Healthy Family Meals
Six Components of Healthy Family Meals Meta-analysis of data from over 29,000 respondents worldwide Turning the TV off, taking time to eat, not arguing at the table: Researchers from the Max Planck Institute for Human Development and the University of Mannheim have evaluated studies examining the quality of family meals. Their findings can serve as guidelines for parents and guardians wanting to help their children ...
mehrTechnische Universität München
Weak spot in pathogenic bacteria: ClpX-ClpP protein complex could be starting point for new antibiotics
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35720/ High resolution images: https://mediatum.ub.tum.de/1520810 NEWS RELEASE Weak spot in pathogenic bacteria ClpX-ClpP protein complex could be starting ...
mehrSysmex Inostics launches two NGS-based liquid biopsy panels for cancer therapy drug development
Hamburg, Germany and Baltimore, Maryland (ots) - Sysmex Inostics announces the availability of the SafeSEQ Breast Cancer and Head and Neck Cancer Panels along with the SafeSEQ Rapid Custom Development program for circulating tumor DNA (ctDNA) analysis. SafeSEQ is a next-generation sequencing (NGS)-based approach that delivers sensitivity comparable to the clinically ...
mehr
Brenntag Food & Nutrition signs agreement with Axiom Foods for EMEA
Dear all, Please find attached the press release of Brenntag Food & Nutrition regarding the agreement with Axiom Foods for the distribution of its plant-based products in EMEA, excluding UK & Ireland. For further information please see the press release. Please do not hesitate to ...
mehrSysmex Inostics publishes first feasibility study of NGS-based liquid biopsy to complement early breast cancer screening by imaging
Hamburg/Baltimore (ots) - Using Sysmex Inostics' novel SafeSEQ next-generation sequencing cell-free DNA technology, investigators from the Biomedical Research Institute of Malaga [(IBIMA)-CIMES-UMA, Malaga Spain] and collaborators have published the first pilot study to examine the use of a non-invasive liquid ...
mehrVBS VetVerlag, Buchhandel und Seminar GmbH
World's Elite Specialists in Veterinary Rehabilitation- and Sports Medicine Meet in Ghent - Eagerly Awaited Standard Work is Going to be Presented by the Main Authors
mehrTechnische Universität München
Dry feed for superfood producers: study investigates nutritional behavior of insects
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10516 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35635/ High resolution pictures: https://mediatum.ub.tum.de/1516504 NEWS RELEASE International study investigates nutritional behavior of insects Dry feed ...
mehrTechnische Universität München
Dizziness of unknown cause: Perception disorders may throw those affected off balance
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 23325 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35543/ High resolution images: https://mediatum.ub.tum.de/1516389 NEWS RELEASE New research findings on dizziness of unknown cause Perception disorders may ...
mehrSysmex obtains Japanese manufacturing and marketing approval for the first blood-based RAS mutation testing for colorectal cancer
Kobe, Japan (ots) - Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM(TM) RAS CRC Kit, used for blood-based circulating tumor DNA (ctDNA) molecular testing of mutations in the RAS gene for advanced colorectal cancer patients. With clinically-validated high sensitivity and ...
mehr
Technische Universität München
Better food quality control: Food profilers develop new methodological approach for food analysis
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: http://www.tum.de/nc/en/about-tum/news/press-releases/details/35607/ High resolution images: https://mediatum.ub.tum.de/1515306 NEWS RELEASE Better food quality ...
mehrTechnische Universität München
Better food quality control: Food profilers develop new methodological approach for food analysis
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: http://www.tum.de/nc/en/about-tum/news/press-releases/details/35607/ High resolution images: https://mediatum.ub.tum.de/1515306 NEWS RELEASE Better food quality ...
mehrTechnische Universität München
Atrial fibrillation: New marker for atrial damage discovered
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 23325 - email: presse@tum.de - web: www.tum.de This text on the web: http://www.tum.de/nc/en/about-tum/news/press-releases/details/35595/ High resolution image: https://mediatum.ub.tum.de/1515114 NEWS RELEASE New marker for atrial damage discovered Protein in blood provides better control of treatment for atrial fibrillation Atrial ...
mehrLiquid Biopsy performance comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS testing published in Scientific Reports (Nature Journal)
Hamburg, Germany (ots) - Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces publication of a study comparing the performance of plasma RAS mutation detection by two commercial liquid biopsy testing platforms, the OncoBEAM(TM) ...
mehrBrenntag Food & Nutrition is the exclusive distributor of Sensus' Frutafit® inulin and Frutalose® oligofructose product lines in South Africa
Dear all, Please find attached the press release of Brenntag Food & Nutrition regarding its exclusive agreement with Sensus for the distribution of Sensus' Frutafit® inulin and Frutalose® oligofructose product lines in South ...
mehrHigh investor density at the Pitch Day hosted by IZB
Ein Dokumentmehr
Fresh momentum in 3D printing
Ein DokumentmehrWord Weer Mens - Cookbook, Specialist Book, Health Book ... and Much More
mehr- 5
seca launches EMR validated line of column scales designed specifically for the North American market
Ein Dokumentmehr - 5
Quantum leaps in medicine and other innovations through additive manufacturing
Ein Dokumentmehr Sysmex Inostics OncoBEAM(TM)-EGFR digital PCR liquid biopsy demonstrates two-fold higher detection of p.T790M mutations in 183 NSCLC patients in comparison study
Hamburg/Baltimore (ots) - Sysmex Inostics announces the publication of clinical research conducted as part of the CIRculating CANcer (CIRCAN) Program at the Lyon Cancer Institute (Lyon, France) comparing the performance of Sysmex Inostics BEAMing (beads, emulsion, amplification, and magnetics) assay for EGFR ...
mehrTechnische Universität München
Artificial intelligence boosts proteome research
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: http://www.tum.de/nc/en/about-tum/news/press-releases/details/article/35470/ Additional press release on the use of artificial intelligence in genome research (appearing later today): http://www.tum.de/nc/en/about-tum/news/press-releases/details/article/35471/ High ...
mehr
Sysmex Inostics' SafeSEQ ER+/HER2- breast cancer panel demonstrates equivalent sensitivity to OncoBEAM(TM) enhanced digital PCR technology for detection of mutations in circulating tumor DNA
Hamburg/Baltimore (ots) - Recent data presented by Dr. Hope S. Rugo from the University of California San Francisco on behalf of investigators in the Translational Breast Cancer Research Consortium at the American Association of Cancer Research 2019 meeting in Atlanta, Georgia demonstrate how Sysmex Inostics' novel ...
mehr- 2
Specific identification of chronic lung disease in premature babies
mehr European Association of E-Pharmacies (EAEP)
EAMSP kicks off information campaign about digitization in German healthcare sector / Fighting the allergic reaction to anything new with #neuschnupfen
mehrBrenntag Food & Nutrition presentation at Vitafoods Europe 2019: Show cases on market mega trends and application development know-how
Dear all, Please find attached a press release from Brenntag Food & Nutrition on its participation in Vitafoods Europe 2019. For further information please see the press release. Please do not hesitate to contact us if you have ...
mehrPluripotency or differentiation - that is the question
mehrEANS-Adhoc: Marinomed Biotech AG announces top line results of the Phase III study for Budesolv
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: ATMARINOMED6, AT0000A1WD52 indexes: stockmarkets: Wien language: English ...
mehr